Viewing StudyNCT00034879



Ignite Creation Date: 2024-05-05 @ 11:26 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00034879
Status: COMPLETED
Last Update Posted: 2013-01-04
First Post: 2002-05-02

Brief Title: Iressa Expanded Access Program EAP
Sponsor:
Organization: AstraZeneca

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: None
Enrollment Type: None
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE3
Observational Models:
Time Perspective List:
Who Masked List: